SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors purchased 1,200 call options on the stock. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
Institutional Trading of SIGA Technologies
A number of institutional investors have recently bought and sold shares of SIGA. Intech Investment Management LLC bought a new position in shares of SIGA Technologies in the 3rd quarter worth $120,000. Charles Schwab Investment Management Inc. grew its position in shares of SIGA Technologies by 5.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 507,262 shares of the company’s stock worth $3,424,000 after buying an additional 24,101 shares during the period. Martingale Asset Management L P grew its position in shares of SIGA Technologies by 108.5% during the 3rd quarter. Martingale Asset Management L P now owns 65,415 shares of the company’s stock worth $442,000 after buying an additional 34,035 shares during the period. Centiva Capital LP increased its stake in shares of SIGA Technologies by 195.9% in the 3rd quarter. Centiva Capital LP now owns 41,936 shares of the company’s stock valued at $283,000 after acquiring an additional 27,766 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its position in shares of SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after acquiring an additional 1,237,620 shares during the period. Institutional investors and hedge funds own 55.40% of the company’s stock.
SIGA Technologies Stock Up 0.4 %
SIGA Technologies stock opened at $5.50 on Thursday. The business’s 50-day simple moving average is $5.81 and its 200 day simple moving average is $6.41. The stock has a market cap of $392.90 million, a price-to-earnings ratio of 4.58 and a beta of 0.98. SIGA Technologies has a 12-month low of $5.16 and a 12-month high of $12.83.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
- Five stocks we like better than SIGA Technologies
- Investing In Preferred Stock vs. Common Stock
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Capture the Benefits of Dividend Increases
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Plot Fibonacci Price Inflection Levels
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.